Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
4 studies found for:    19264687 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Unknown  Mepolizumab Treatment for Rhinovirus-induced Asthma Exacerbations
Conditions: Asthma;   Viral Infection
Interventions: Drug: Mepolizumab;   Drug: Placebo
2 Completed The Prednisone-sparing Effect of Anti-IL-5 Antibody (SB-240563)
Condition: Asthma
Intervention: Drug: SB-240563 (Mepolizumab)
3 Enrolling by invitation Anti-Interleukin-5 (IL5) Monoclonal Antibody (MAb) in Prednisone-dependent Eosinophilic Asthma
Conditions: Severe Persistent Asthma;   Eosinophilic Bronchitis
Interventions: Biological: Reslizumab;   Drug: Placebo
4 Active, not recruiting Effects of cKit Inhibition by Imatinib in Patients With Severe Refractory Asthma (KIA)
Condition: Asthma
Interventions: Drug: Imatinib mesylate;   Drug: Placebo

Study has passed its completion date and status has not been verified in more than two years.